Terms: = Endocrine gland cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Clinical Outcome
4 results:
1. Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.
Zhang Q; Zhou W; Yu S; Ju Y; To SKY; Wong AST; Jiao Y; Poon TCW; Tam KY; Lee LTO
Oncogene; 2021 Jan; 40(1):97-111. PubMed ID: 33082557
[TBL] [Abstract] [Full Text] [Related]
2. Promoter CpG island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer.
Dai W; Zeller C; Masrour N; Siddiqui N; Paul J; Brown R
Clin Cancer Res; 2013 Oct; 19(20):5788-5797. PubMed ID: 23965899
[TBL] [Abstract] [Full Text] [Related]
3. WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin.
Wei W; Li H; Li N; Sun H; Li Q; Shen X
Pancreatology; 2013; 13(4):384-92. PubMed ID: 23890137
[TBL] [Abstract] [Full Text] [Related]
4. High prevalence of c-RET expression in papillary thyroid carcinomas from the Korean population.
Lee S; Hong SW; Moon WC; Oh MR; Lee JK; Ahn CW; Cha BS; Kim KR; Lee HC; Lim SK
Thyroid; 2005 Mar; 15(3):259-66. PubMed ID: 15785245
[TBL] [Abstract] [Full Text] [Related]